Investing.com - U.S. futures pointed to a lower open on Monday, as trading remained thin after the Easter holiday and Boeing slumped amid reports of sloppy production at its...
Investing.com – Israel stocks were higher after the close on Sunday, as gains in the Communication, Biomed and Technology sectors led shares higher. At the close in Tel Aviv, the...
Investing.com – Israel stocks were lower after the close on Thursday, as losses in the Biomed, Oil & Gas and Technology sectors led shares lower. At the close in Tel Aviv, the TA...
Introduction Although many Health Technology Sector companies have significantly outperformed the market on a long-term basis, they have significantly underperformed the market...
Perrigo Company plc (NYSE:PRGO) reported fourth-quarter 2018 adjusted earnings of 97 cents per share, which missed the Zacks Consensus Estimate of 98 cents. The bottom line also...
|Type||5 mins||15 mins||Hourly||Daily||Monthly|
|Moving Averages||Strong Sell||Strong Sell||Strong Sell||Strong Sell||Sell|
|Technical Indicators||Strong Sell||Strong Sell||Strong Sell||Strong Sell||Strong Sell|
|Summary||Strong Sell||Strong Sell||Strong Sell||Strong Sell||Strong Sell|
Filter Table By:
|Pattern||Timeframe||Reliability||Candles Ago||Candle Time|
|Falling Three Methods||1D||3||Apr 17, 2019|
|Doji Star Bearish||1H||3||Apr 22, 2019 01:00PM|
|Abandoned Baby Bearish||30||5||Apr 22, 2019 01:30PM|
|Bullish doji Star||1M||6||Oct 18|
|Doji Star Bearish||30||6||Apr 22, 2019 01:00PM|
Perrigo Company PLC (Perrigo), formerly Perrigo Company Limited, is an over-the-counter (OTC) consumer goods and specialty pharmaceutical company. The Company's segments include Consumer Healthcare (CHC), Branded Consumer Healthcare (BCH), Prescription Pharmaceuticals (Rx) and Specialty Sciences. It manufactures OTC healthcare products and supplies infant formulas for the store brand market. It is also a provider of generic extended topical prescription products. The CHC segment is focused on the sale of OTC store brand products. The BCH segment develops, manufactures, markets and distributes various European OTC brands. The Rx segment develops, manufactures and markets a portfolio of generic and specialty pharmaceutical prescription drugs. The Specialty Sciences segment consists of assets focused on the treatment of multiple sclerosis, specifically in connection with the drug, Tysabri.Read More
|U.S. Commodity Futures Trading Commission (United States), Securities and Exchange Commission (United States)||$0||Start Trading|
|Cyprus Securities and Exchange Commission (Cyprus), The Financial Conduct Authority (United Kingdom), Australian Securities and Investments Commission (Australia)||$200||Start Trading|
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.